ASTION PHARMA A/S: Financial statements 2022
CVR: 34224781
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 206,156 and a net result of DKK 25,126 compared with DKK -6,272,681 the year before. Equity in the 2022 report amounted to DKK -5,550,379.
- Gross Profit
- DKK 206,156
- Profit/Loss
- DKK 25,126
- Equity
- DKK -5,550,379
- Total Assets
- DKK 2,991,679
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 206K | 25K | -5.6M | - |
| 2021 | - | -1.4M | -6.3M | -5.6M | - |
| 2020 | - | -3.6M | -4.8M | 697K | - |
| 2019 | - | -1.8M | -1.8M | - | - |
| 2018 | - | -392K | -409K | 500K | - |
Official annual report
Keep an eye on ASTION PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ASTION PHARMA A/S has published its annual report for 2021. Gross profit came to DKK -1,354,194, and the net result was DKK -6,272,681.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.